CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
CVS Health (CVS) shares tick higher on surprise Q2 beat
August 2, 2023 6:42 AM EDTCVS Health (NYSE: CVS) shares rose modestly in pre-open trading Wednesday after a surprise beat on the top and bottom line in the second quarter and a confirming of its full year adjusted EPS, although GAAP EPS for the year was trimmed.
The pharmacy and healthcare giant reported that adjusted EPS for the quarter fell to $2.21 from $2.53 last year, but beat the consensus of $2.13.
Revenue rose 10.3% to $88.921 billion, beating the... More



